Ceilings Revisited
A question was asked about the last post that warrants top billing:
“Buprenorphine acts similar to opioid agonists in lower doses, with the same addictive potential as oxycodone or heroin. In higher doses—doses above 8 mg or 8000 micrograms per day—the ‘ceiling effect’ eliminates interest and cravings for the drug.”
I’m not sure I followed this. Can you explain more? What would you think about someone who is taking 1-2mg of Suboxone twice a day without a prescription, and says they want to stay on that dose once they find a prescriber? Are they better off on 8mg or more per day, or would it be ok for a prescriber to keep them at the lower dose? Is the answer the same if they hope to taper off the medication completely within a year (they don’t feel able to do this on their own right now, but hope to be able to when some life circumstances change). Thanks!
This gets a bit complicated, but I’ll do my best. A couple background issues; buprenorphine has a ‘ceiling’ to its effect, meaning that beyond a certain dose, increases in dose do not cause greater opioid effect. That is the mechanism for how buprenorphine blocks cravings.


As a solo-practice psychiatrist, I am more connected to the cost/value equation of my services than the typical system-employed physician. I’ve also written in prior posts about my concerns with modern psychiatry. I have worked in a variety of settings over the course of my career, and I realize that coming to an understanding of something as complicated as another person’s subjective life experience is a very difficult endeavor.
I think that it is because of my own experiences as a study participant back in medical school that I get such a kick out of volunteer studies today. Years ago, my classmates and I were paid to undergo bronchial lavage (a procedure where a tube is passed into the lung and the alveoli rinsed with fluid—all while wide awake), to be infected with the cold virus and then receive various treatments (administered by squirting substances up the nose), and to take antidepressants or other medications to allow researchers to screen for side effects. The greater the inconvenience, risk of injury, or physical discomfort, the bigger the payoff for test subjects.
I relapsed in 2000 after seven years of sobriety, and my attachment to opioids progressed much more rapidly than during my initial addiction. I wrote a post a number of months ago that described ‘living on two levels,’ and that was my experience at the time—as if one part of my personality was frantically taking ever-increasing doses of dangerous narcotics while the other part, horrified, looked on.
In my last post I shared a comment from a reader that included the following:
This is part one of a three-part discussion about will power; look for the rest of the story next week, after the Packers beat the Bears in the NFC Conference Championship.
In response to my last post, a reader, Sunkissed, wrote about the many consequences of active addiction, and noted that the consequences including spiritual impairment and the loss of self-esteem are as valid indicators of ‘addiction severity’ as are consequential effects on earning power—perhaps even more valid.
This is another section of my unpublished book, Clean Enough. I describe stages in the process of addiction that I’ve noticed in opioid addicts presenting for treatment. I must point out that these stages have not been validated by clinical research, but rather are drawn from simple observation. Read on:
Addiction fits any definition of ‘disease’ that a person might use. Addiction is progressive; there are familial and environmental influences; the course of a case of addiction bears certain similarities between individuals; the progression of illness is predictable; and recovery from illness is possible with appropriate treatment.